1. 97PCommunity-driven development of a modified progression-free survival ratio for precision oncology trials. (7th November 2019) Authors: Mock, A; Heilig, C E; Kreutzfeldt, S; Hübschmann, D; Heining, C; Schröck, E; Brors, B; Stenzinger, A; Jäger, D; Schlenk, R F; Glimm, H; Fröhling, S; Horak, P Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 81PComprehensive genomic and transcriptomic profiling in advanced-stage cancers and rare malignancies: Clinical results from the MASTER trial of the German Cancer Consortium. (7th November 2019) Authors: Horak, P; Kreutzfeldt, S; Mock, A; Heining, C; Heilig, C E; Möhrmann, L; Uhrig, S; Hübschmann, D; Beck, K; Richter, D; Schlenk, R F; Klink, B; Hutter, B; Weichert, W; Stenzinger, A; Schröck, E; Brors, B; Glimm, H; Fröhling, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗